Literature DB >> 32585958

Rac1 Promotes Cell Motility by Controlling Cell Mechanics in Human Glioblastoma.

Jing Xu1,2, Nicola Galvanetto1, Jihua Nie1,3, Yili Yang2, Vincent Torre1,2,3,4.   

Abstract

The failure of existing therapies in treating human glioblastoma (GBM) mostly is due to the ability of GBM to infiltrate into healthy regions of the brain; however, the relationship between cell motility and cell mechanics is not well understood. Here, we used atomic force microscopy (AFM), live-cell imaging, and biochemical tools to study the connection between motility and mechanics in human GBM cells. It was found thatRac1 inactivation by genomic silencing and inhibition with EHT 1864 reduced cell motility, inhibited cell ruffles, and disrupted the dynamics of cytoskeleton organization and cell adhesion. These changes were correlated with abnormal localization of myosin IIa and a rapid suppression of the phosphorylation of Erk1/2. At the same time, AFM measurements of the GBM cells revealed a significant increase in cell elasticity and viscosity following Rac1 inhibition. These results indicate that mechanical properties profoundly affect cell motility and may play an important role in the infiltration of GBM. It is conceivable that the mechanical characters might be used as markers for further surgical and therapeutical interventions.

Entities:  

Keywords:  Rac1; cell adhesion; cell mechanics; cell motility; cytoskeleton

Year:  2020        PMID: 32585958     DOI: 10.3390/cancers12061667

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  5 in total

1.  The Cytoskeleton Effectors Rho-Kinase (ROCK) and Mammalian Diaphanous-Related (mDia) Formin Have Dynamic Roles in Tumor Microtube Formation in Invasive Glioblastoma Cells.

Authors:  Kathryn N Becker; Krista M Pettee; Amanda Sugrue; Kevin A Reinard; Jason L Schroeder; Kathryn M Eisenmann
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

2.  Universal Markers Unveil Metastatic Cancerous Cross-Sections at Nanoscale.

Authors:  Evangelos Bakalis; Angelo Ferraro; Vassilios Gavriil; Francesco Pepe; Zoe Kollia; Alkiviadis-Constantinos Cefalas; Umberto Malapelle; Evangelia Sarantopoulou; Giancarlo Troncone; Francesco Zerbetto
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575

3.  Unfolding and identification of membrane proteins in situ.

Authors:  Nicola Galvanetto; Zhongjie Ye; Arin Marchesi; Simone Mortal; Sourav Maity; Alessandro Laio; Vincent Torre
Journal:  Elife       Date:  2022-09-12       Impact factor: 8.713

4.  Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models.

Authors:  Georgina A Cardama; Julian Maggio; Lucas Valdez Capuccino; Nazareno Gonzalez; Valentina Matiller; Hugo H Ortega; German R Perez; Ignacio A Demarco; Eduardo Spitzer; Daniel E Gomez; Pablo Lorenzano Menna; Daniel F Alonso
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

5.  Polycystin-1 and hydrostatic pressure are implicated in glioblastoma pathogenesis in vitro.

Authors:  Ilianna Zoi; Antonios N Gargalionis; Kostas A Papavassiliou; Narjes Nasiri-Ansari; Christina Piperi; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  J Cell Mol Med       Date:  2022-02-01       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.